United States

Analyst Research Report Snapshot


Dainippon Sumitomo Pharma Co., Ltd.






27 May 2015





Companies referenced:


Available for Immediate Download

Dainippon Sumitomo Pharma Co., Ltd. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company. Features: - Detailed information on Dainippon Sumitomo Pharma Co., Ltd. required for business and competitor intelligence needs - A study of the major internal and external factors affecting Dainippon Sumitomo Pharma Co., Ltd. in the form of a SWOT analysis - An in-depth view of the business model of Dainippon Sumitomo Pharma Co., Ltd. including a breakdown and examination of key business segments - Intelligence on Dainippon Sumitomo Pharma Co., Ltd.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Dainippon Sumitomo Pharma Co., Ltd., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Dainippon Sumitomo Pharma (DSP or 'the group') is a Japan-based global provider of pharmaceutical products. It is a subsidiary of Sumitomo Chemical. The group primarily operates in Asia and North America. It is headquartered in Osaka, Japan, and employed 7,129 people as of March 31, 2013. The group recorded revenues of JPY347,724 million (approximately $4,207.5 million) during the financial year ended March 2013 (FY2013), a decrease of 0.8% over FY2012. The operating profit of the group was JPY25,044 million (approximately $303 million) in FY2013, an increase of 22.8% over FY2012. The net profit was JPY10,044 million (approximately $121.5 million) in FY2013, an increase of 16.4% over FY2012. Reasons to Purchase: - Gain understanding of Dainippon Sumitomo Pharma Co., Ltd. and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Dainippon Sumitomo Pharma Co., Ltd. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Dainippon Sumitomo Pharma Co., Ltd.’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.